yingweiwo

Interleukin Related

Interleukin Related

White blood cells (leukocytes), which are a subset of cytokines (secreted proteins and signaling molecules), were the first to be observed to express interleukins. Interleukins are crucial for the immune system's proper operation, and there have been rare cases of their deficiency that have all been associated with autoimmune disorders or immune deficiencies. Helper CD4 T lymphocytes, along with monocytes, macrophages, and endothelial cells, produce the majority of interleukins. They support the growth and differentiation of hematopoietic cells, including T and B lymphocytes. The development of spatial memories in mice has also been linked to interleukin receptors on astrocytes in the hippocampus.

Interleukin Related related products

Structure Cat No. Product Name CAS No. Product Description
BAA473 V75020 BAA473 27240-87-5 BAA473 is a bile acid analogue and a potent pyranoid inflammasome activator that induces IL-18 secretion by activating the inflammasome in myeloid and intestinal epithelial cells.
Basiliximab (CHI 621) V74950 Basiliximab (CHI 621) 179045-86-4 Basiliximab (CHI 621) is a recombinant chimeric mouse/human IgG1 monoclonal anti-interleukin-2 receptor antibody.
Bermekimab (MABp1) V74956 Bermekimab (MABp1) 1401965-15-8 Bermekimab (MABp1) is a human monoclonal antibody (mAb) targeting interleukin-1alpa (IL-1α).
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) V74937 Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) 1418205-77-2 Bimekizumab (Bimzelx; Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanized monoclonal antibody (mAb) that selectively neutralizes IL-17A and IL-17F.
BMS-986251 V67806 BMS-986251 2460133-35-9 BMS-986251 is an orally bioactive, selective RORγt inverse agonist/activator with EC50 of 12 nM for RORγt GAL4.
Brazikumab (AMG 139; MEDI2070) V74997 Brazikumab (AMG 139; MEDI2070) 1610353-18-8 Brazikumab (AMG 139) is a human IgG2 monoclonal antibody (mAb) that selectively binds to the p19 subunit of IL-23 with a Kd of 0.138 nM for human IL-23.
Briakinumab (ABT-874) V74958 Briakinumab (ABT-874) 339308-60-0 Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody (mAb).
Brodalumab (AMG 827; KHK4827) V74949 Brodalumab (AMG 827; KHK4827) 1174395-19-7 Brodalumab (AMG 827) is an anti-human interleukin 17 receptor (IL-17R) IgG2 monoclonal antibody (mAb) indicated for the study of moderate to severe plaque psoriasis and rheumatoid arthritis.
Camidanlumab (HuMax-TAC) V74983 Camidanlumab (HuMax-TAC) 921618-45-3 Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody (mAb).
Camoteskimab (AVTX-007; CERC-007; MEDI 2338) V74969 Camoteskimab (AVTX-007; CERC-007; MEDI 2338) 2492472-82-7 Camoteskimab (AVTX-007) is a fully human, high-affinity anti-IL-18 monoclonal antibody (mAb).
Canakinumab (Ilaris; ACZ 885) V74935 Canakinumab (Ilaris; ACZ 885) 914613-48-2 Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody (mAb).
Casdozokitug (SRF-388) V75051 Casdozokitug (SRF-388) 2643331-37-5 Casdozokitug (SRF-388) is an IgG1κ antibody targeting IL27.
CC-90002 V74942 CC-90002 2085844-54-6 CC-90002 is a humanized anti-CD47 monoclonal antibody (mAb).
Cendakimab (Cendakimab; RPC 4046; ABT 308; CC-93538) V75003 Cendakimab (Cendakimab; RPC 4046; ABT 308; CC-93538) 2151032-62-9 Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized recombinant monoclonal antibody (mAb) against IL-13.
Cergutuzumab amunaleukin (CEA-IL2v; RG 7813; RO 6895882) V74972 Cergutuzumab amunaleukin (CEA-IL2v; RG 7813; RO 6895882) 1509916-03-3 Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine based on carcinoembryonic antigen (CEA) targeting IL-2 variants.
Citrullinated LL-37 2cit V78806 Citrullinated LL-37 2cit Citrullinated LL-37 2cit is a citrullinated LL-37 peptide.
CTX-471 V75034 CTX-471 2377152-49-1 CTX-471 is a fully human monoclonal antibody (mAb) against CD137.
Dectrekumab (Detrekumab; QAX576) V75041 Dectrekumab (Detrekumab; QAX576) 1528523-94-5 Dectrekumab (QAX576) is a humanized monoclonal antibody (mAb) targeting IL-13.
Depemokimab (GSK-3511294) V75004 Depemokimab (GSK-3511294) 2243274-14-6 Depemokimab (GSK-3511294) is a long-acting anti-IL-15 monoclonal antibody (mAb).
Diacerein-d6 (Diacerhein-d6; Diacetylrhein-d6) V75029 Diacerein-d6 (Diacerhein-d6; Diacetylrhein-d6) 1325559-27-0 Diacerein-d6 is the deuterium labelled form of Diacerein.
Contact Us